Special Issue "Recent Advances in Pregnancy-Related Complications"
A special issue of Reproductive Medicine (ISSN 2673-3897).
Deadline for manuscript submissions: 31 December 2023 | Viewed by 8336
Interests: pregnancy-related complications; pathogenesis; diagnosis/prognosis biomarkers; epigenetics; extracellular nucleic acids in maternal circulation; postpartum/postnatal short-term and long-term consequences
Special Issues, Collections and Topics in MDPI journals
Special Issue in International Journal of Molecular Sciences: Pathogenesis of Pregnancy-Related Complications 2.0
Special Issue in International Journal of Molecular Sciences: Pathogenesis of Pregnancy-Related Complication
Special Issue in International Journal of Molecular Sciences: Pathogenesis of Pregnancy-Related Complication 2023
Topics: Pathogenesis of Pregnancy-Related Complications
Topics: Pathogenesis of Pregnancy-Related Complications 2.0
Preeclampsia, HELLP syndrome, fetal growth restriction, gestational diabetes mellitus, preterm birth (preterm prelabor rupture of membranes and spontaneous preterm labor) and invasive placenta are major complications responsible for maternal and perinatal morbidity and mortality. The elucidation of the molecular mechanisms related to the initiation and onset of severe pregnancy-related complications enables the identification of potential biomarkers for an early stratification of at-risk patients. Additionally, pregnancy-related complications induce long-term metabolic and vascular abnormalities that might increase the overall risk of metabolic, cardiovascular, cerebrovascular, kidney, and other diseases later in life in mothers and their offspring. This Special Issue aims to provide an overview of the latest research on the molecular and cellular mechanisms associated with pregnancy-related complications, as well as the contribution of pregnancy-related complications to the later development of various diseases. This will include the underlying mechanisms, diagnostics/prognostics and treatment strategies associated with pregnancy-related complications and will be of interest to scientists and clinicians working in this quickly expanding area.
Prof. Dr. Ilona Hromadnikova
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Reproductive Medicine is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- gestational hypertension
- HELLP syndrome
- fetal growth restriction
- gestational diabetes mellitus
- preterm birth
- invasive placenta